Healthy returns
13 September 2012
The constant need to produce new drugs and fuel profits means that pharmaceutical giant AstraZeneca spends £6.5 billion a year on purchasing. The people who spend it are facing some serious challenges, discovers Liam O’Brien
The impressive research and development base of AstraZeneca at Alderley Park, just outside Macclesfield, is every bit the high-technology facility you would expect of the third largest pharmaceutical company in the world.
The lavish glass-and-steel laboratories on the 50-acre science park site house 3,000 scientists, many of whom are responsible for some of the...